The diagnostic value of interleukin 35 as a septic biomarker: A meta-analysis
Authors:
Open Access
- 10 November 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 9, 999892
Abstract
Background: There is growing evidence that interleukin 35 (IL-35) represents a potential diagnostic biomarker for sepsis. The purpose of this meta-analysis was to evaluate the overall diagnostic accuracy of IL-35 in sepsis.Materials and methods: From October 1998 to May 2022, set retrieval standards were used to search literature Databases. Each included study was assessed diagnostic accuracy study quality assessment tool. Two researchers independently extracted the data and research features. If there are differences, the issue will be resolved by mutual agreement. Meta-disc and Stata software were utilized to calculate combined sensitivity, specificity, and summary diagnostic odds ratio (SDOR), I2, or Cochrane Q in order to detection for heterogeneity, and meta-regression was performed to figure out the cause of heterogeneity. Utilizing funnel plots, we tested for publication bias.Results: In this meta-analysis, eight publications were included. The combined sensitivity, specificity, and DOR were 0.87 (95% CI, 0.77–0.93), 0.73 (95% CI, 0.60–0.83), and 18.26 (95% CI, 9.70–34.37), respectively. In addition, 0.88 (95% CI, 0.84–0.90) was the area under the summary receiver operating characteristic curve. In the heterogeneity analysis, the sensitivity of comprehensive I2 statistic was 84.38, and the specificity was 87.82. Deeks’ funnel plot showed no publication bias in this meta-analysis (P = 0.17). A meta-analysis revealed that IL-35 has a modest sensitivity (AUC = 0.88) for diagnosing sepsis. We also compared the diagnostic accuracy of IL-35 and procalcitonin (PCT), and our results showed that the diagnostic accuracy parameters for IL-35 were significantly higher than those for PCT.Conclusion: Interleukin 35 is a valuable biomarker for the early detection of sepsis. However, the data should be combined with clinical symptoms, signs, and laboratory and microbiological findings.Keywords
Funding Information
- National Natural Science Foundation of China
This publication has 23 references indexed in Scilit:
- IL-35 Pretreatment Alleviates Lipopolysaccharide-Induced Acute Kidney Injury in Mice by Inhibiting NF-κB ActivationInflammation, 2017
- Interleukin 35: A novel candidate biomarker to diagnose early onset sepsis in neonatesClinica Chimica Acta, 2016
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- IL-35 is elevated in clinical and experimental sepsis and mediates inflammationClinical Immunology, 2015
- Accuracy of Presepsin in Sepsis Diagnosis: A Systematic Review and Meta-AnalysisPLOS ONE, 2015
- Human placental trophoblasts express the immunosuppressive cytokine IL-35Human Immunology, 2013
- Interleukin 35: A Key Mediator of Suppression and the Propagation of Infectious ToleranceFrontiers in Immunology, 2013
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- The inhibitory cytokine IL-35 contributes to regulatory T-cell functionNature, 2007
- Procalcitonin as an early marker of infection in neonates and childrenThe Lancet Infectious Diseases, 2004